aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.
Also called NCT02513797
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 600 participants
- Sponsor
- Registry
-
NCT02513797
-
- Other papers using this trial's data
- Effect of Left Atrial Size and Volume Reduction on Pulmonary Vein Isolation Efficacy in Patients With Persistent and Longstanding Persistent Atrial Fibrillation: Subset Analysis From the aMAZE Trial
- Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT02513797. Randomized; no masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2021-04-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
- Acronym
- aMAZE
- Condition
- Atrial Fibrillation
- Intervention (Device)
- LARIAT + PVI
- Intervention (Device)
- Pulmonary Vein Isolation
- Lead sponsor
- AtriCure, Inc.
Record details
- Record id
cardio:ct-nct02513797- Content hash
4c20542e2811ed534c1a30b129ddc19ea8ce15b5f84439b2d9c6dbc9d1fdd63f